AngioDynamics (NASDAQ:ANGO) released its quarterly earnings data on Wednesday. The medical instruments supplier reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.03, MarketWatch Earnings reports. AngioDynamics had a negative net margin of 62.90% and a positive return on equity of 0.18%. The firm had revenue of $72.80 million for the quarter, compared to analysts’ expectations of $67.33 million. During the same quarter last year, the business posted $0.06 earnings per share. The company’s revenue for the quarter was up 4.0% compared to the same quarter last year.
Shares of AngioDynamics stock opened at $18.57 on Friday. The company has a market capitalization of $704.73 million, a PE ratio of 517.67 and a beta of 0.89. The company has a debt-to-equity ratio of 0.09, a quick ratio of 2.25 and a current ratio of 3.57. The company has a 50-day simple moving average of $14.29 and a two-hundred day simple moving average of $11.16. AngioDynamics has a one year low of $7.48 and a one year high of $19.52.
Several equities research analysts recently weighed in on the stock. Zacks Investment Research cut shares of AngioDynamics from a “buy” rating to a “hold” rating and set a $15.00 price target on the stock. in a research report on Tuesday, December 1st. Raymond James restated a “neutral” rating on shares of AngioDynamics in a research report on Thursday, November 26th. BidaskClub raised shares of AngioDynamics from a “hold” rating to a “buy” rating in a research note on Wednesday. Finally, Canaccord Genuity reaffirmed a “hold” rating and set a $14.00 price objective on shares of AngioDynamics in a research note on Wednesday, September 30th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $15.67.
AngioDynamics, Inc designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors.
Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.